Pay in 4 interest-free payments of $6.09 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
MECHANISM CATEGORIES RESEARCH CONDITIONS SAFETY Side effects Hypoglycemia (binds insulin receptor at higher doses) Theoretical organ enlargement with chronic high-dose Theoretical concerns in active malignancy (IGF-1 axis) Known interactions Insulin / sulfonylureas (hypoglycemia risk) Concurrent rhGH not standard Contraindications Active malignancy (IGF-1 axis growth signaling) Pregnancy/lactation (unstudied) Diabetic retinopathy (theoretical exacerbation) REGULATORY STATUS FDA Not FDA-approved
Cerebral folate receptor autoantibodies in autism spectrum disorder
Elevated circulating IGF-1 inhibits GHRH secretion and directly suppresses somatotroph GH release, reducing endogenous IGF-1 synthesis for the duration of IGF-1 LR3 administration
Fruit, 31:1 Extract
US$ 28.07
US$ 25.51
US$ 27.42
US$ 21.41
